QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Clinical trial NCT03387098 · TERMINATED
Trial details
- NCT number
- NCT03387098
- Sponsor
- ImmunityBio, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-28
- Primary completion
- 2018-09-12
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.